Linda Avey

CEO, | Co-founder, 23andMe Linda Avey on Linkedin

Linda Avey is CEO of, a precision health company. Ms. Avey has been a Member of the Scientific Advisory Board at Verily Life Sciences LLC since 2018. She was Co-founder of 23andMe. She has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences. She also spent time at Spotfire helping scientists understand the power of data visualization and at Applied BioSystems during the early days of the human genome project. Her primary interest is the acceleration of personalized medicine, using genetic profiles to target the right drug to the right person at the correct dose.